首站-论文投稿智能助手
典型文献
Decoding the complexity of metastasis
文献摘要:
Cancer metastasis remains one of the most confounding questions in oncology1,2. Although current cutting-edge techniques enable very early detection of tumors, profiling whether a tumor has already begun to spread and where it has attempted to colonize remains a major hurdle. Indeed, metastatic seeding events exhibit remarkable temporal and spatial -heterogeneity, wherein the origin (primary site) and destination (metastatic site) are highly dynamic. For example, liver metastasis is particularly common and remains a lead-ing cause of mortality3. Primary cancers are diverse and can include gastrointestinal cancer, such as colorectal cancer and pancreatic cancer, as well as cancers of extraperitoneal origin, such as breast cancer, which has heterogeneous clinical phe-notypes and a range of therapeutic responses. Because exist-ing knowledge of cross-tissue metastasis remains far from complete, the generation of a unified pan-cancer metastasis map remains a pressing need. In this perspective, we outline the growing advances in metastasis biology, with a focus on the challenges in using high--throughput technologies and the state-of-the-art -theories among the metastasis research community.
文献关键词:
作者姓名:
Yingcheng Wu;Tiancheng Zhang;Xiaoming Zhang;Qiang Gao
作者机构:
Department of Liver Surgery and Transplantation,Key Laboratory of Carcinogenesis and Cancer Invasion(Ministry of Education),Liver Cancer Institute,Zhongshan Hospital,Fudan University,Shanghai 200032,China;The Center for Microbes,Development and Health,Key Laboratory of Molecular Virology and Immunology,Institute Pasteur of Shanghai,Chinese Academy of Sciences,Shanghai 200031,China;Key Laboratory of Medical Epigenetics and Metabolism,Institutes of Biomedical Sciences,Fudan University,Shanghai 200032,China;State Key Laboratory of Genetic Engineering,Fudan University,Shanghai 200433,China
引用格式:
[1]Yingcheng Wu;Tiancheng Zhang;Xiaoming Zhang;Qiang Gao-.Decoding the complexity of metastasis)[J].癌症生物学与医学(英文版),2022(03):284-288
A类:
oncology1,mortality3,notypes
B类:
Decoding,complexity,metastasis,Cancer,remains,most,confounding,questions,Although,current,cutting,techniques,enable,very,early,detection,tumors,profiling,whether,has,already,begun,spread,attempted,colonize,major,hurdle,Indeed,metastatic,seeding,events,exhibit,remarkable,temporal,spatial,heterogeneity,wherein,origin,primary,site,destination,are,highly,dynamic,For,example,liver,particularly,common,lead,Primary,cancers,diverse,include,gastrointestinal,such,colorectal,pancreatic,well,extraperitoneal,breast,which,heterogeneous,clinical,phe,range,therapeutic,responses,Because,exist,knowledge,cross,tissue,far,from,complete,generation,unified,map,pressing,need,this,perspective,outline,growing,advances,biology,focus,challenges,using,throughput,technologies,state,theories,among,research,community
AB值:
0.633443
相似文献
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
Zhang Weiwei;Yan Wenji;Qian Niansong;Han Quanli;Zhang Weitao;Dai Guanghai-Chinese People’s Liberation Army Medical School, Beijing 100853, China;Department of the Third Health Care, The Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The Hainan Medical Center, Chinese People’s Liberation Army General Hospital, Sanya 572022, China;Cancer Center, Beijing Tongren Hospital Affiliated to Capital Medical University, Economic and Technological Development Zone, Beijing 100176, China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Bone metastasis of hepatocellular carcinoma:facts and hopes from clinical and translational perspectives
Zhao Huang;Jingyuan Wen;Yufei Wang;Shenqi Han;Zhen Li;Xuemei Hu;Dongling Zhu;Zhenxiong Wang;Junnan Liang;Huifang Liang;Xiao-ping Chen;Bixiang Zhang-Hepatic Surgery Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Clinical Medical Research Center of Hepatic Surgery at Hubei Province,Wuhan 430030,China;Hubei Key Laboratory of Hepato-Pancreatic-Biliary Diseases,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Radiology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Nuclear Medicine and PET Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Radiology,Guangzhou First People's Hospital,School of Medicine,South China University of Technology,Guangzhou 510180,China;Key Laboratory of Organ Transplantation,Ministry of Education;Key Laboratory of Organ Transplantation,National Health Commission;Key Laboratory of Organ Transplantation,Chinese Academy of Medical Sciences,Wuhan 430030,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。